Aller au contenu. | Aller à la navigation

Outils personnels

Navigation
Vous êtes ici : Accueil / Équipes / Mort Cellulaire Régulée et Génétique de la Neurodégénerescence - B. Mollereau / Publications / A burning question from the first international BPAN symposium: is restoration of autophagy a promising therapeutic strategy for BPAN?

A burning question from the first international BPAN symposium: is restoration of autophagy a promising therapeutic strategy for BPAN?

Bertrand Mollereau, Susan J Hayflick, Ricardo Escalante, Mario Mauthe, Apostolos Papandreou, Arcangela Iuso, Marion Celle, Sahra Aniorte, Abdul R Issa, Jean P Lasserre, Gaetan Lesca, Stéphane Thobois, Pauline Burger, and Ludivine Walter (2023)

Autophagy.

Beta-propeller protein-associated neurodegeneration (BPAN) is a rareneurodegenerative disease associated with severe cognitive and motor deficits.BPAN pathophysiology and phenotypic spectrum are still emerging due to the factthat mutations in the WDR45 (WD repeat domain 45) gene, a regulator ofmacroautophagy/autophagy, were only identified a decade ago. In the firstinternational symposium dedicated to BPAN, which was held in Lyon, France, apanel of international speakers, including several researchers from the autophagycommunity, presented their work on human patients, cellular and animal models,carrying WDR45 mutations and their homologs. Autophagy researchers found anopportunity to explore the defective function of autophagy mechanisms associatedwith WDR45 mutations, which underlie neuronal dysfunction and early death.Importantly, BPAN is one of the few human monogenic neurological diseasestargeting a regulator of autophagy, which raises the possibility that it is arelevant model to directly assess the roles of autophagy in neurodegeneration andto develop autophagy restorative therapeutic strategies for more commondisorders.

 
automatic medline import

Actions sur le document